Caxton Associates (New York)’s Rhythm Pharmaceuticals RYTM Stock Holding History

Caxton Associates (New York)’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell
2024 Q3	$602K	Buy
2022 Q3	–	Sell
2022 Q2	$628K	Buy
2022 Q1	$474K	Sell
2021 Q4	$593K	Buy